Although incretin (GLP-1)-based drugs are highly successful for weight loss, there are some limitations to their use. A modified prolactin-releasing peptide, NN501, causes significant weight

Sebhat et al. present a strategy to mimic bariatric surgery by activating specialized intestinal cells that secrete satiety hormones, including GLP-1. Preclinically, a combination of

A new compass for the SKEPDOC column. This column was founded by Harriet Hall, MD (1945–2023) who wrote it from 2006 to 2023. In 2026,

Key Points KXI is more globally diversified, with nearly 100 holdings, but has a slightly deeper five-year drawdown than PBJ, and a weaker five-year total

Pfizer (NYSE: PFE) is in the Wall Street doghouse. It is currently viewed as an also-ran in the drug sector, lagging far behind peers like

Published on January 19, 2026 9:20 PM GMT The main thing to know this time around is that the whole crazy ‘what is causing the

Twelve percent of Americans reportedly take a GLP-1, according to a recent poll

Airlines stand to save a potential $580 million as travelers slim down thanks to the effects of weight-loss drugs, a new study found. Sheila Kahyaoglu,

Full version can be found on Dread: https://dreadytofatroptsdj6io7l3xptbet6onoyno2yv7jicoxknyazubrad.onion/post/a9fa8a5deb3a54b33fb7 Tor browser is required to access any .onion links. 🦸 ✅ SUPERLIST MARKETS ✅ – /d/DarkMatterMarket –

Weight loss drugs like Wegovy and Zepbound are causing chains to rethink their offerings.

PULSE POINTS WHAT HAPPENED: Airlines may see cost savings on fuel if weight loss drugs contribute to lighter passengers, according to a Jefferies Research Services

Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus  NBC News ‘Bar Rescue’ host Jon Taffer on new restaurant reality: Smaller portions, lighter

Shares of Novo Nordisk NVO rose 9.1% on Friday after the company reportedly recorded strong early prescription trends just one week following the early-January U.S.

Post Content

A new meta-study — a study of studies — reveals an inconvenient truth about weight loss itself: Willpower still matters. Manufacturers of GLP-1 injectables like

The weight loss drug boom could drive fuel costs down.

More than 1 in 3 US adults has this condition, and most aren’t aware of it.

In an industry known for pushing the bounds of human innovation, tech elites are now trying to push the bounds of their own bodies. The

GLP-1 agonist injections, although originally developed to treat type 2 diabetes, have changed how we approach obesity.1 The two main types now in use—semaglutide (Wegovy),

Trisha Parsicha in The Washington Post: In the original clinical trials of GLP-1 medications for weight loss, the most common side effects were gastrointestinal, including nausea, vomiting

The GLP-1 trend is changing the food landscape dramatically. Some sectors stand a chance to win, such as functional ingredients, while others, like alcohol or

GLP-1 medications do seem to have gut health benefits. GLP-1s may lower the risk of stomach ulcers, help liver problems and even reduce colorectal cancer

Next gen weight-loss medications are powerful — but eating too little can put some patients at serious nutritional risk. Medscape Medical News

Post Content

WEIGHT-loss jab users hungry for protein will help to raise meat prices by up to a fifth this year, an expert has warned. Oisin Hanrahan,

Uncle Sam thinks you’re probably eating wrong, and he’s got some advice.  Out: processed carbohydrates and added sugar.  In: fat and protein, especially the animal-flesh

The food, beauty and pharmaceutical industries poison our self-image. GLP-1 drugs will only make them richer – and strengthen the hold they have over us

Key Points Vanguard’s low-fee mutual funds and ETFs make it easy for individual investors to build diversified portfolios. The Vanguard Health Care ETF has outperformed

AS trials suggest they can treat ever more illnesses and more people use them to slim down, it is clear weight loss jabs are here

submitted by /u/Sad-Complaint2678 [link] [comments]

Serena Williams recently stunned her fans after sharing a carousel of photos showing her dancing, squatting low, and proudly calling out her “Meg Thee Stallion

The idea of tracking blood sugar without needles has challenged health tech for years. For people with diabetes, constant monitoring is critical, yet the tools

By Aaron Bolton, MTPR, KFF Health News SANDY, Utah — Just outside Salt Lake City sits an old, two-story, brick hotel. It’s been given new

By DEE-ANN DURBIN Meals and snacks with “GLP-1 Friendly” labels on the packaging are becoming more common in U.S. supermarkets as a growing number of

By STEPHEN WADE If winning gold medals were the only standard, almost all Olympic athletes would be considered failures. Related Articles Food companies are targeting

Pharmac received two applications to fund Wegovy or semaglutide – a GLP-1 receptor agonist for weight loss.

Oprah Winfrey is on a book tour promoting her new book, “Enough: Your Weight and What It’s Like to Be Free.” In 2023, she reportedly

M&S, Morrisons and Ocado among retailers bringing out ranges targeting shoppers taking Wegovy or similar Veganuary and dry January are among the new year health